Acope, Chloe Elise B.

HRN: 20-71-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
CEFUROXIME 750MG (VIAL)
05/26/2022
06/02/2022
IV
330mg
Q8h
Uti
Waiting Final Action 
05/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/28/2022
06/03/2022
İVT
2.25g
Q6
T/c Acute Glomerulonephritis, Pcap C

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: